Drug Profile
Oxybutynin intravesical - Situs
Alternative Names: I-OxyLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Situs Corporation
- Class Alkynes; Antispasmodics; Carbocyclic acids; Cyclohexanes; Diethylamines; Esters; Mandelic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Overactive bladder
Most Recent Events
- 18 Jan 2001 Situs has received 2 US patents for the UROS infusor
- 01 Sep 2000 Situs has received a US patent for the formulation and delivery of I-OXYTM
- 02 Aug 2000 New profile